Because targeting Brd4 slows down tumor growth partially through downregulating Myc expression, we then investigated whether the downregulation of glucose transporter GLUT1 resulted from the reduced Myc expression in Brd4-/- CD8+ T cells (30, 41). This evidence concerns the gene SLC2A1 and neoplasm.